参考文献/References:
[1].Bakris G, Ali W, Parati G. ACC/AHA Versus ESC/ESH onhypertension guidelines: JACC guideline comparison[J]. J Am Coll Cardiol, 2019, 73(23): 3018-3026.
[2].Arendse LB, Danser AHJ, Poglitsch M, et al. Novel therapeutic approaches targeting the renin-angiotensin system and associated peptides in hypertension?and heart failure[J]. Pharmacol Rev, 2019, 71(4): 539-570.?
[3].王晓蓉,任明.三种基因多态性与原发性高血压的研究进展[J].中华老年心脑血管病杂志,2019,1(1):97-99.
[4].Raman M, Cobb MH. TGF-beta?regulation by emilin1: new links in the etiology of?hypertension[J]. Cell, 2006, 124(5): 893-895.
[5].Demura M, Saijoh K. The role of?DNA methylation?in?hypertension[J]. Adv Exp Med Biol, 2017, 956:583-598.
[6].邵琳琳,姜月华,杨传华,等.长链非编码RNA在原发性高血压及其并发症中的作用机制研究进展[J].中华高血压杂志,2018,26(11):1013-1019.
[7].Li X, Cai W, Xi W, et al. MicroRNA-31 Regulates immunosuppression in ang (angiotensin Ⅱ)-induced?hypertension?by targeting ppp6c (protein phosphatase 6c)[J]. Hypertension, 2019, 73(5): e14-e24.?
[8].Wang YN, Shan K, Yao MD, et al. long noncoding rna-gas5: a novel regulator of?hypertension-induced?vascular remodeling[J]. Hypertension,2016, 68(3):736-748.
[9].Pironti G, Strachan RT, Abraham D, et al. Circulating exosomes induced by cardiac pressure overload contain functional angiotensin Ⅱ type 1 receptors[J]. Circulation,2015,131(24):2120-2130.
[10].Perez-Hernandez J,?Olivares D,?Forner MJ, et al. Urinary?exosome?miR-146a is a potential marker of albuminuria in essential?hypertension[J]. J Transl Med, 2018, 16(1): 228.
[11].谢丹,张沐诗,李树春.肠道菌群与高血压相关性的研究进展[J].实用医药杂志,2019,:177-181.
[12].Tanaka M, Itoh H. hypertension?as a metabolic disorder and the novel role of the gut[J].Curr Hypertens Rep, 2019, 21(8): 63.?
[13].叶澍承,杨宁,杨国红,等.肠道菌群参与高血压形成的机制[J].医学综述,2018,24(22):4390-4394.
[14].Mikolajczyk TP, Guzik TJ. Adaptive Immunity inHypertension[J]. Curr Hypertens Rep, 2019, 21(9): 68.?
[15].Tang H, Wu K, Wang J, et al. Pathogenic role of?mTORC1?and mTORC2 in pulmonary?hypertension[J]. JACC Basic Transl Sci, 2018, 3(6): 744-762.
[16].Schiffrin EL. Vascular remodeling?in?hypertension: mechanisms and treatment[J]. Hypertension, 2012, 59(2): 367-374.
[17].Renna NF, de Las Heras N, Miatello RM. Pathophysiology of?vascular remodeling?in?hypertension[J].Int J Hypertens, 2013, 2013: 808353.?
[18].?lvarez-Miguel I, Cidad P, Pérez-García MT, et al. Differences in?TRPC3?and TRPC6 channels assembly in mesenteric vascular smooth muscle cells in essential?hypertension[J]. J Physiol, 2017, 595(5): 1497-1513.
[19].宋金萍,王松,郭丽荣.上皮细胞钠离子通道及其相关调控因素在盐敏感性高血压中的作用[J].中华高血压杂志,2019,:20-24.
[20].张闻丽,马宏.H型高血压的研究现状及进展[J].中外医学研究,2019,:186-188.
[21].Renna NF, Oxidative stress, vascular remodeling, and vascular inflammation in?hypertension[J].Int J Hypertens, 2013, 2013: 710136.?
[22].Fernández-Ruiz I. Hypertension: Promising?mitochondria-targeting drug for PAH[J]. Nat Rev Cardiol, 2018, 15(1): 4-5.
[23].张志军,冯奕奕.高血压中枢发病机制的研究进展[J].医学理论与实践,2018,31(16):2389-2390.
[24].Charoen P, Eu-Ahsunthornwattana J, Thongmung N, et al. Contribution of four polymorphisms inrenin-angiotensin-aldosterone-related genes tohypertension?in a thai population[J]. Int J Hypertens, 2019, 2019: 4861081.
[25].Rodriguez-Padial L, Akerstr?m F, Barderas MG, et al. progression of renal insufficiency in patients with essential?hypertension?treated with?renin angiotensin aldosterone?system blockers: an electrocardiographic correlation[J]. Diseases, 2017 , 5(4). pii: E33.?
[26].Seccia TM, Caroccia B, Muiesan ML, et al. Atrial fibrillation and arterial?hypertension: A common duet with dangerous consequences where therenin angiotensin-aldosterone?system plays an important role[J].Int J Cardiol, 2016, 206: 71-76.
[27].Cano-Martínez LJ, Marroquín C, Coral-Vázquez RM, et al. Expression of adipokines and their receptors in adipose tissue of women with class 3?obesity?with or without?hypertension[J]. Gene, 2019, 702: 148-152.?
[28].Hall JE, do Carmo JM, da Silva AA, et al. Obesity, kidney dysfunction and hypertension: mechanistic links[J]. Nat Rev Nephrol, 2019, 15(6): 367-385.
[29].吕婷婷,孙丙毅,李圆,等.高血压发病机制及相关进展[J].医学综述,2018, 24(23): 4689-4693.
相似文献/References:
[1]孙刚,黄冠华,综述.高血压合并心力衰竭的治疗策略[J].心血管病学进展,2016,(2):201.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.027]
SUN Gang,HUANG Guanhua.Treatment Strategy of Hypertension with Heart Failure[J].Advances in Cardiovascular Diseases,2016,(9):201.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.027]
[2]范贵娟,综述,徐瑞,等.盐敏感性高血压的研究进展[J].心血管病学进展,2016,(4):364.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.010]
FAN Guijuan,XU Rui.Research Progress of Salt Sensitive Hypertension[J].Advances in Cardiovascular Diseases,2016,(9):364.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.010]
[3]陈源源.钙通道阻滞剂在降压治疗中的应用[J].心血管病学进展,2015,(6):662.[doi:10.3969/j.issn.1004-3934.2015.06.002]
CHEN Yuanyuan.Application of Calcium Channel Blockers in Hypertension Treatment[J].Advances in Cardiovascular Diseases,2015,(9):662.[doi:10.3969/j.issn.1004-3934.2015.06.002]
[4]张瑞 毛露 孙硕 Dirk Hermann 陈艾东.内皮素-1干预成为高血压治疗新靶点的展望[J].心血管病学进展,2019,(7):969.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.000]
ZHANG Rui MAO LuSUN ShuoDIRK Hermann CHEN Aidong.The Prospect of Endothelin-1 Intervention as A New Target for the Treatment of Hypertension[J].Advances in Cardiovascular Diseases,2019,(9):969.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.000]
[5]张毅,柳志红.动态血压监测在高血压中的应用现状与问题[J].心血管病学进展,2019,(6):848.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.003]
ZHANG Yi,LIU Zhihong.Current status and nsolved Pproblems of Ambulatory Blood Pressure Monitoring for the Management of Hypertension[J].Advances in Cardiovascular Diseases,2019,(9):848.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.003]
[6]黄秋瑾 胡蓉.高血压合并糖尿病患者血压控制率和控制目标的探讨[J].心血管病学进展,2019,(7):973.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.002]
HUANG QiujinHU Rong.Discussion on Blood Pressure Control Rate and Control Target in Patients with Hypertension Complicated with Diabetes[J].Advances in Cardiovascular Diseases,2019,(9):973.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.002]
[7]张旭明 王曦.高血压对认知功能的影响[J].心血管病学进展,2019,(7):977.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.003]
ZHANG Xuming,WANG Xi.The Relationship Between Hypertension and Cognitive Function[J].Advances in Cardiovascular Diseases,2019,(9):977.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.003]
[8]凌梦军 陈明凌梦军.阻塞性睡眠呼吸暂停低通气综合征与高血压关系的研究进展[J].心血管病学进展,2019,(5):722.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.015]
[9]李波 郭毅 田进文 邓珏琳.高血压合并2型糖尿病的治疗进展[J].心血管病学进展,2019,(9):1196.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.002]
LI Bo,GUO Yi,TIAN Jinwen,et al.Therapy in Hypertensive Patients with Type 2 Diabetes Mellitus[J].Advances in Cardiovascular Diseases,2019,(9):1196.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.002]
[10]王继航 赵施皓 李开亮 田进文 李玉龙 付士辉 沈明志 邓珏琳.远程医疗在高血压病管理中的研究进展[J].心血管病学进展,2019,(9):1199.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.003]
WANG Jihang,ZHAO Shihao,LI Kailiang,et al.Telemedicine in Hypertension Management[J].Advances in Cardiovascular Diseases,2019,(9):1199.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.003]